MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 137 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,335,000 | -64.2% | 1,076,803 | -11.2% | 0.05% | -65.2% |
Q1 2017 | $3,734,000 | -41.8% | 1,212,478 | -22.9% | 0.13% | -43.1% |
Q4 2016 | $6,418,000 | -37.3% | 1,572,978 | -2.4% | 0.23% | -37.6% |
Q3 2016 | $10,234,000 | +17.6% | 1,611,678 | -0.2% | 0.37% | +17.4% |
Q2 2016 | $8,703,000 | -11.7% | 1,614,678 | +37.2% | 0.32% | -10.2% |
Q1 2016 | $9,851,000 | +27.1% | 1,176,978 | +12.0% | 0.35% | +40.6% |
Q4 2015 | $7,751,000 | -13.4% | 1,051,178 | 0.0% | 0.25% | -13.7% |
Q3 2015 | $8,946,000 | -31.2% | 1,051,178 | 0.0% | 0.29% | -20.9% |
Q2 2015 | $12,998,000 | +225.0% | 1,051,178 | +212.2% | 0.37% | +217.2% |
Q1 2015 | $4,000,000 | +8.3% | 336,700 | +3.1% | 0.12% | +5.5% |
Q4 2014 | $3,692,000 | +543.2% | 326,700 | +399.5% | 0.11% | +511.1% |
Q3 2014 | $574,000 | +42.1% | 65,400 | +18.1% | 0.02% | +50.0% |
Q2 2014 | $404,000 | +192.8% | 55,400 | +102.2% | 0.01% | +140.0% |
Q1 2014 | $138,000 | -5.5% | 27,400 | 0.0% | 0.01% | -28.6% |
Q4 2013 | $146,000 | – | 27,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 2,244,080 | $12,096,000 | 4.51% |
ALTFEST L J & CO INC | 39,491 | $1,653,000 | 1.15% |
GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $446,000 | 0.44% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 9,074,557 | $48,912,000 | 0.40% |
Virtus ETF Advisers LLC | 87,477 | $472,000 | 0.35% |
Cannell & Co. | 1,614,678 | $8,703,000 | 0.32% |
Birchview Capital, LP | 44,000 | $237,000 | 0.17% |
STONERIDGE INVESTMENT PARTNERS LLC | 180,534 | $973,000 | 0.14% |
HighPoint Advisor Group LLC | 8,484 | $344,000 | 0.12% |
MARINER INVESTMENT GROUP LLC | 63,090 | $340,000 | 0.12% |